D. E. Shaw & Co., Inc. Rx Sight, Inc. Put Options Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
Put Options
2 transactions
Others Institutions Holding RXST
# of Institutions
189Shares Held
36.2MCall Options Held
42.2KPut Options Held
103K-
Ra Capital Management, L.P. Boston, MA3.7MShares$27.2 Million1.05% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$17.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$16.7 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.77MShares$13 Million0.08% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M1.23MShares$9.04 Million0.01% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $203M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...